Please assess the completion status of the following clinical trial:

Trial Title: KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* HIV infected subjects that are naive to anti-HIV therapy.~* History of a positive HIV test.~* At least 1000 copies/mL of HIV in their blood as screening.~Exclusion Criteria:~* Active HIV-related diseases.~* Taking other investigational drugs.~* Pregnant or breastfeeding females.~* Not be suitable to participate per investigator opinion.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).